Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. News
  7. Press Releases
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ BIOCARTIS GROUP NV
06/04BIOCARTISá : Results of the Extraordinary Shareholders' Meeting held on 4 June 2..
PU
06/04PRESS RELEASE BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Me..
AQ
05/17PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
05/14BIOCARTISá : Results of the Shareholders' Meetings held on 14 May 2021
PU
05/14PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
05/11BIOCARTISá : Receives EUR 1.4m Grant to Support Development of New Idylla™..
PU
05/11PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Receives EUR 1.4m Grant to Support ..
AQ
05/04BIOCARTISá : Announces New Collaboration with AstraZeneca to Expand Availability..
PU
05/04PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces New Collaboration with Astra..
AQ
04/22BIOCARTISá : Q1 2021 business update
PU
04/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and SkylineDx Sign Collaboration to..
AQ
04/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis q1 2021 business update
AQ
04/20BIOCARTISá : Announces US FDA 510(k) submission of its Idylla™ MSI Test
PU
04/20PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces US FDA 510(k) submission ..
AQ
04/13BIOCARTISá : Invitation to the Annual and Extraordinary Shareholders' Meetings
PU
04/13PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual and Extraordinary Sh..
AQ
04/01BIOCARTISá : Announces Publication of 2020 Annual Report
PU
04/01PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2020 Annua..
AQ
03/22BIOCARTISá : Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Solut..
PU
03/22PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Launches Idylla™ GeneFusion A..
AQ
02/25PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2020 results and 2021 out..
AQ
02/18BIOCARTISá : Announces 2020 Full Year Results on 25 February 2021
PU
02/18PRESS NEWS BIOCARTIS GROUP NV : Biocartis announces 2020 full year results on 25..
AQ
02/02BIOCARTISá : New US Studies Demonstrate Idylla™ Allows Rapid First Assessm..
PU
02/02PRESS NEWS BIOCARTIS GROUP NV : New US Studies Demonstrate Idylla™ Allows ..
AQ
01/11BIOCARTISá : Meets 2020 key objectives
PU
01/11PRESS NEWS BIOCARTIS GROUP NV : Biocartis meets 2020 key objectives
AQ
2020BIOCARTISá : Disclosure of outstanding voting securities
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Disclosure of outstanding voting securities
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces the Conversion of EUR 15 mil..
AQ
2020BIOCARTISá : Disclosure of a transparency notification
PU
2020PRESS NEWS BIOCARTIS GROUP NV - REGU : Disclosure of a transparency notification
AQ
2020BIOCARTISá : Announces Publication of Large Multi-Center Comparison Study with I..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Publication of Large Multi-C..
AQ
2020BIOCARTISá : Announces Ten Idylla™ Studies to be Published at Virtual AMP ..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Ten Idylla™ Studies t..
AQ
2020BIOCARTISá : Q3 2020 business update
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis q3 2020 business update
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces CE-marking of its Fully Auto..
AQ
2020BIOCARTISá : Announces Partnership with Endpoint Health to Develop Novel Compani..
PU
2020BIOCARTISá : and GeneproDx To Collaborate on Fully Automated ThyroidPrint« test ..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis and GeneproDx To Collaborate on Fully..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Partnership with Endpoint He..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis and Exact Sciences Agree to End Collab..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Update on the partnership with Exact Sciences
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Market Release of SeptiCyte..
AQ
2020CORPORATE STATEMENT : Biocartis Joins COVID-19 Testing Industry Consortium of Ni..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Receives EUR 1.2 million Grant for Dev..
AQ
2020BIOCARTISá : Results of the Extraordinary Shareholders' Meeting held on 25 Septe..
PU
2020PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
2020BIOCARTISá : Large Prospective Lung Cancer Study To Be Presented at ESMO Congres..
PU
2020BIOCARTISá : Large Prospective Lung Cancer Study To Be Presented at ESMO Congres..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders' Me..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis announces h1 2020 results
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
2020PRESS NEWS BIOCARTIS GROUP NV : Biocartis Expands Collaboration with LifeArc
AQ
2020BIOCARTISá : announces 2020 half-year results on 3 September 2020
PU
2020BIOCARTISá : Announces 2020 half-year results on 3 september 2020
AQ
2020BIOCARTISá : Invitation to the Extraordinary Shareholders' Meeting
PU
2020PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : US Multicenter Study Shows Idylla™ Allo..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Creates New Share Option Plan
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Q1 2020 Business Update
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Development of Idylla&tr..
AQ
2020BIOCARTIS GROUP NV : Important Notice Regarding the Annual and Extraordinary Sha..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Important Notice Regarding the Annual and Ext..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual and Extraordinary Sh..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2019 Annua..
AQ
2020BIOCARTISá : Announces Co-Commercialization of the SeptiCyte« RAPID Test on Idyl..
AQ
2020BIOCARTISá : Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aim..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2019 results and 2020 out..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Creates New Share Option Plan & Can..
AQ
2020PRESS RELEASE BIOCARTIS GROUP NV : Biocartis to Host Webcast for Announcement 2..
AQ
2020PRESS RELEASE BIOCARTIS GROUP : Biocartis announces resignation cfo
AQ
1  2  3  4  5Next
Upcoming event on BIOCARTIS GROUP NV
09/02/21